Mark Bodenrader

This profile gathers the share dealings of Mark Bodenrader in Cerevel Therapeutics Holdings, Inc. We count 6 filings; the first trade dates from 1 June 2023 and the latest from 1 August 2024.

The open-market record consists of 2 sales worth €356k, with no purchase. Outside the open market, there are 3 option exercises.

The newest entry dates from 5 August 2024: a transaction, in Cerevel Therapeutics Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.